scispace - formally typeset
J

James A. Hay

Researcher at Harvard University

Publications -  37
Citations -  3339

James A. Hay is an academic researcher from Harvard University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 13, co-authored 31 publications receiving 1676 citations. Previous affiliations of James A. Hay include Imperial College London.

Papers
More filters
Journal ArticleDOI

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.

Nuno R. Faria, +74 more
- 21 May 2021 - 
TL;DR: In this article, the authors used a two-category dynamical model that integrates genomic and mortality data to estimate that P.1 may be 1.7-to 2.4-fold more transmissible and that previous (non-P.1) infection provides 54 to 79% of the protection against infection with P.
Journal ArticleDOI

Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening.

TL;DR: It is demonstrated that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity, and should prioritize accessibility, frequency, and sample-to-answer time.
Posted ContentDOI

Surveillance testing of SARS-CoV-2

TL;DR: It is concluded that surveillance should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary.
Posted ContentDOI

Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil

Nuno R. Faria, +74 more
- 03 Mar 2021 - 
TL;DR: In this paper, the emergence and circulation of a new SARS-CoV-2 variant of concern, lineage P.1, that acquired 17 mutations, including a trio in the spike protein (K417T, E484K and N501Y) associated with increased binding to the human ACE2 receptor.